Lupin Limited - India's Leading Pharma Company
|
|
ICMR HOME | Case Studies Collection
To download Lupin Limited - India's Leading Pharma Company case study
(Case Code: BSTR191) click on the button below, and select the case from the list of available cases:
OR
Buy With PayPal
|
» Business Strategy Case Studies
» Case Studies Collection
» Business Strategy Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company
Please note:
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
Chat with us
Please leave your feedback
|
Case Details: |
Price: |
| Case Code |
: |
BSTR191 |
Electronic Format: Rs.
300;
Courier (within India):Rs. 25 Extra
ThemesGrowth Strategy |
| Case Length |
: |
14 Pages |
| Period |
: |
1998-2005 |
| Organization |
: |
Lupin Laboratories |
| Pub Date |
: |
2006 |
| Teaching Note |
: |
Not Available |
| Countries
|
: |
India |
| Industry |
: |
Pharma and Biotech
|
Abstract:
|
The case presents the strategies adopted by Lupin Limited to emerge as one of
the leading pharmaceutical companies in India. For the fiscal 2004-05, Lupin
reported revenues of Rs. 12.12 billion, placing it among the top six companies
in the Indian pharma industry. The company aims at achieving the revenues of US$
1 billion by 2009. To achieve this target, Lupin has made heavy investments in
R&D, manufacturing processes and is focusing on exports. Notwithstanding Lupin's
success till date and its plans for future growth, the company faces significant
threat in the form of product patents, high debts and rising competition from
both local and foreign pharma companies. The case highlights the challenges
facing Lupin and its plans to overcome these challenges.
|
|
Issues:
» Recent trends in the Indian Pharmaceutical Industry
» Lupin's journey from a drug manufacturer to a national level pharma
company
» Growth Strategies of Lupin Limited
» Importance of patents (product and process) in the pharma industry
» Product patent regime in India
Contents:
Keywords:
Lupin Limited, Indian Pharmaceutical Industry, Product patent, Process
patents, Active pharmaceutical ingredients, Drug price control, Generics,
Anti-tuberculosis Drugs, Pediatrics segment, Over-the-counter drugs
Lupin Limited - India's Leading Pharma Company
- Next Page>>
|
|
